These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7122666)

  • 1. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala.
    Deminière JM; Taghzouti K; Tassin JP; Le Moal M; Simon H
    Psychopharmacology (Berl); 1988; 94(2):232-6. PubMed ID: 3127850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR; Carey RJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity responses to morphine and amphetamine in rats with elevated NE levels in the pons.
    Olds ME; Fobes JL
    Pharmacol Biochem Behav; 1981 Aug; 15(2):167-71. PubMed ID: 7312890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.